Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2007
Event: Entry into a Material Definitive Agreement regarding an accelerated share repurchase.
Key Financial Metrics
This filing does not report standard operating metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data disclosed relates to a capital allocation transaction:
- Share Repurchase Amount: $750 million
- Initial Repurchase Price: $59.59 per share
- Counterparties: Citibank, N.A. and JP Morgan Chase Bank, National Association
- Program Status: Utilization of the previously board-authorized $750 million stock repurchase program.
Material Changes
The filing discloses the execution of an Accelerated Share Repurchase (ASR) agreement. This transaction represents a significant reduction in the company's authorized share repurchase capacity, as the full $750 million authorization was utilized in this single agreement. The final number of shares repurchased is subject to adjustment based on the terms of the ASR.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard nature of an ASR agreement. The primary contingency noted is that the initial repurchase price of $59.59 per share is subject to adjustment, meaning the final share count and average price will be determined at the settlement of the agreement.
Investor Verification Checklist
- Verify the final settlement date and total number of shares repurchased under the ASR agreement.
- Confirm the final average price per share after adjustments are applied.
- Review the company's remaining authorized share repurchase capacity (currently $0 based on this filing).
- Check subsequent filings for the impact of this transaction on the company's cash balance and liquidity.